Hydralazine administration activates sympathetic preganglionic neurons whose activity mobilizes glucose and increases cardiovascular function

Lindsay M. Parker, Mohd Hanafi Ahmad Damanhuri, Sophie P S Fletcher, Ann K. Goodchild

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hypotensive drugs have been used to identify central neurons that mediate compensatory baroreceptor reflex responses. Such drugs also increase blood glucose. Our aim was to identify the neurochemical phenotypes of sympathetic preganglionic neurons (SPN) and adrenal chromaffin cells activated following hydralazine (HDZ; 10 mg/kg) administration in rats, and utilize this and SPN target organ destination to ascribe their function as cardiovascular or glucose regulating. Blood glucose was measured and adrenal chromaffin cell activation was assessed using c-Fos immunoreactivity (-ir) and phosphorylation of tyrosine hydroxylase, respectively. The activation and neurochemical phenotype of SPN innervating the adrenal glands and celiac ganglia were determined using the retrograde tracer cholera toxin B subunit, in combination with in situ hybridization and immunohistochemistry. Blood glucose was elevated at multiple time points following HDZ administration but little evidence of chromaffin cell activation was seen suggesting non-adrenal mechanisms contribute to the sustained hyperglycemia. 16±0.1% of T4-T11 SPN contained c-Fos and of these: 24.3±1.4% projected to adrenal glands and 29±5.5% projected to celiac ganglia with the rest innervating other targets. 62.8±1.4% of SPN innervating adrenal glands were activated and 29.9±3.3% expressed PPE mRNA whereas 53.2±8.6% of SPN innervating celiac ganglia were activated and 31.2±8.8% expressed PPE mRNA. CART-ir SPN innervating each target were also activated and did not co-express PPE mRNA. Neurochemical coding reveals that HDZ administration activates both PPE+SPN, whose activity increase glucose mobilization causing hyperglycemia, as well as CART+SPN whose activity drive vasomotor responses mediated by baroreceptor unloading to raise vascular tone and heart rate.

Original languageEnglish
Pages (from-to)25-34
Number of pages10
JournalBrain Research
Volume1604
DOIs
Publication statusPublished - 16 Apr 2015

Fingerprint

Hydralazine
Neurons
Glucose
Chromaffin Cells
Sympathetic Ganglia
Adrenal Glands
Blood Glucose
Hyperglycemia
Messenger RNA
Phenotype
Pressoreceptors
Baroreflex
Cholera Toxin
Tyrosine 3-Monooxygenase
Pharmaceutical Preparations
In Situ Hybridization
Blood Vessels
Heart Rate
Immunohistochemistry
Phosphorylation

Keywords

  • Glucose mobilization
  • Hydralazine
  • Hypotension
  • Neurochemical phenotype
  • Sympathetic preganglionic neurons

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Hydralazine administration activates sympathetic preganglionic neurons whose activity mobilizes glucose and increases cardiovascular function. / Parker, Lindsay M.; Ahmad Damanhuri, Mohd Hanafi; Fletcher, Sophie P S; Goodchild, Ann K.

In: Brain Research, Vol. 1604, 16.04.2015, p. 25-34.

Research output: Contribution to journalArticle

@article{22ef0947af284fc78fdad8f4d6c3f978,
title = "Hydralazine administration activates sympathetic preganglionic neurons whose activity mobilizes glucose and increases cardiovascular function",
abstract = "Hypotensive drugs have been used to identify central neurons that mediate compensatory baroreceptor reflex responses. Such drugs also increase blood glucose. Our aim was to identify the neurochemical phenotypes of sympathetic preganglionic neurons (SPN) and adrenal chromaffin cells activated following hydralazine (HDZ; 10 mg/kg) administration in rats, and utilize this and SPN target organ destination to ascribe their function as cardiovascular or glucose regulating. Blood glucose was measured and adrenal chromaffin cell activation was assessed using c-Fos immunoreactivity (-ir) and phosphorylation of tyrosine hydroxylase, respectively. The activation and neurochemical phenotype of SPN innervating the adrenal glands and celiac ganglia were determined using the retrograde tracer cholera toxin B subunit, in combination with in situ hybridization and immunohistochemistry. Blood glucose was elevated at multiple time points following HDZ administration but little evidence of chromaffin cell activation was seen suggesting non-adrenal mechanisms contribute to the sustained hyperglycemia. 16±0.1{\%} of T4-T11 SPN contained c-Fos and of these: 24.3±1.4{\%} projected to adrenal glands and 29±5.5{\%} projected to celiac ganglia with the rest innervating other targets. 62.8±1.4{\%} of SPN innervating adrenal glands were activated and 29.9±3.3{\%} expressed PPE mRNA whereas 53.2±8.6{\%} of SPN innervating celiac ganglia were activated and 31.2±8.8{\%} expressed PPE mRNA. CART-ir SPN innervating each target were also activated and did not co-express PPE mRNA. Neurochemical coding reveals that HDZ administration activates both PPE+SPN, whose activity increase glucose mobilization causing hyperglycemia, as well as CART+SPN whose activity drive vasomotor responses mediated by baroreceptor unloading to raise vascular tone and heart rate.",
keywords = "Glucose mobilization, Hydralazine, Hypotension, Neurochemical phenotype, Sympathetic preganglionic neurons",
author = "Parker, {Lindsay M.} and {Ahmad Damanhuri}, {Mohd Hanafi} and Fletcher, {Sophie P S} and Goodchild, {Ann K.}",
year = "2015",
month = "4",
day = "16",
doi = "10.1016/j.brainres.2015.01.049",
language = "English",
volume = "1604",
pages = "25--34",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Hydralazine administration activates sympathetic preganglionic neurons whose activity mobilizes glucose and increases cardiovascular function

AU - Parker, Lindsay M.

AU - Ahmad Damanhuri, Mohd Hanafi

AU - Fletcher, Sophie P S

AU - Goodchild, Ann K.

PY - 2015/4/16

Y1 - 2015/4/16

N2 - Hypotensive drugs have been used to identify central neurons that mediate compensatory baroreceptor reflex responses. Such drugs also increase blood glucose. Our aim was to identify the neurochemical phenotypes of sympathetic preganglionic neurons (SPN) and adrenal chromaffin cells activated following hydralazine (HDZ; 10 mg/kg) administration in rats, and utilize this and SPN target organ destination to ascribe their function as cardiovascular or glucose regulating. Blood glucose was measured and adrenal chromaffin cell activation was assessed using c-Fos immunoreactivity (-ir) and phosphorylation of tyrosine hydroxylase, respectively. The activation and neurochemical phenotype of SPN innervating the adrenal glands and celiac ganglia were determined using the retrograde tracer cholera toxin B subunit, in combination with in situ hybridization and immunohistochemistry. Blood glucose was elevated at multiple time points following HDZ administration but little evidence of chromaffin cell activation was seen suggesting non-adrenal mechanisms contribute to the sustained hyperglycemia. 16±0.1% of T4-T11 SPN contained c-Fos and of these: 24.3±1.4% projected to adrenal glands and 29±5.5% projected to celiac ganglia with the rest innervating other targets. 62.8±1.4% of SPN innervating adrenal glands were activated and 29.9±3.3% expressed PPE mRNA whereas 53.2±8.6% of SPN innervating celiac ganglia were activated and 31.2±8.8% expressed PPE mRNA. CART-ir SPN innervating each target were also activated and did not co-express PPE mRNA. Neurochemical coding reveals that HDZ administration activates both PPE+SPN, whose activity increase glucose mobilization causing hyperglycemia, as well as CART+SPN whose activity drive vasomotor responses mediated by baroreceptor unloading to raise vascular tone and heart rate.

AB - Hypotensive drugs have been used to identify central neurons that mediate compensatory baroreceptor reflex responses. Such drugs also increase blood glucose. Our aim was to identify the neurochemical phenotypes of sympathetic preganglionic neurons (SPN) and adrenal chromaffin cells activated following hydralazine (HDZ; 10 mg/kg) administration in rats, and utilize this and SPN target organ destination to ascribe their function as cardiovascular or glucose regulating. Blood glucose was measured and adrenal chromaffin cell activation was assessed using c-Fos immunoreactivity (-ir) and phosphorylation of tyrosine hydroxylase, respectively. The activation and neurochemical phenotype of SPN innervating the adrenal glands and celiac ganglia were determined using the retrograde tracer cholera toxin B subunit, in combination with in situ hybridization and immunohistochemistry. Blood glucose was elevated at multiple time points following HDZ administration but little evidence of chromaffin cell activation was seen suggesting non-adrenal mechanisms contribute to the sustained hyperglycemia. 16±0.1% of T4-T11 SPN contained c-Fos and of these: 24.3±1.4% projected to adrenal glands and 29±5.5% projected to celiac ganglia with the rest innervating other targets. 62.8±1.4% of SPN innervating adrenal glands were activated and 29.9±3.3% expressed PPE mRNA whereas 53.2±8.6% of SPN innervating celiac ganglia were activated and 31.2±8.8% expressed PPE mRNA. CART-ir SPN innervating each target were also activated and did not co-express PPE mRNA. Neurochemical coding reveals that HDZ administration activates both PPE+SPN, whose activity increase glucose mobilization causing hyperglycemia, as well as CART+SPN whose activity drive vasomotor responses mediated by baroreceptor unloading to raise vascular tone and heart rate.

KW - Glucose mobilization

KW - Hydralazine

KW - Hypotension

KW - Neurochemical phenotype

KW - Sympathetic preganglionic neurons

UR - http://www.scopus.com/inward/record.url?scp=84925623053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925623053&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2015.01.049

DO - 10.1016/j.brainres.2015.01.049

M3 - Article

C2 - 25662772

AN - SCOPUS:84925623053

VL - 1604

SP - 25

EP - 34

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -